{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:26:48Z","timestamp":1765618008853,"version":"3.48.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.arcmed.2025.103336","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:51:49Z","timestamp":1761825109000},"page":"103336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Future of Pancreatic Cancer Therapy: Getting Better, But not Good Enough Ye"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7289-2891","authenticated-orcid":false,"given":"Johannes","family":"Klose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Doebereiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Sunami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-079X","authenticated-orcid":false,"given":"Artur","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Ronellenfitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorg","family":"Kleeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2025.103336_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2025.103336_bib0002","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2025.103336_bib0003","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0004","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/CCO.0000000000000962","article-title":"Adjuvant and neoadjuvant approaches in pancreatic cancer","volume":"35","author":"Conroy","year":"2023","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102817","article-title":"Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis","volume":"145","author":"Parmar","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0006","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/genes11010006","article-title":"Metastasis in pancreatic ductal adenocarcinoma: current standing and methodologies","volume":"11","author":"Ayres Pereira","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0007","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.3390\/cancers15113049","article-title":"Adjuvant FOLFIRINOX in patients with resectable pancreatic cancer is effective but rarely feasible in real life: is Neoadjuvant FOLFIRINOX a better option?","volume":"15","author":"Maman","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0008","article-title":"Neoadjuvant chemotherapy with Gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer: results of the randomized phase II\/III prep-02\/JSAP05 trial","author":"Unno","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","article-title":"Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial","volume":"9","author":"Labori","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0010","doi-asserted-by":"crossref","first-page":"zrae172","DOI":"10.1093\/bjsopen\/zrae172","article-title":"Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis","volume":"9","author":"Dickerson","year":"2025","journal-title":"BJS Open"},{"key":"10.1016\/j.arcmed.2025.103336_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033452","article-title":"Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1)","volume":"9","author":"Wei","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.arcmed.2025.103336_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102067","article-title":"Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus","volume":"8","author":"Leonhardt","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.arcmed.2025.103336_bib0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.surg.2016.02.019","article-title":"Synchronous resections of hepatic oligometastatic pancreatic cancer: disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis","volume":"160","author":"Tachezy","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.arcmed.2025.103336_bib0014","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1200\/JCO.24.00081","article-title":"Addition of metastasis-directed therapy to systemic therapy for oligometastatic pancreatic ductal adenocarcinoma (EXTEND): A multicenter, randomized phase II trial","volume":"42","author":"Ludmir","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0015","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1186\/s12885-021-08966-3","volume":"21","author":"Gebauer","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2025.103336_bib0016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12885-025-13573-7","article-title":"Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial","volume":"25","author":"Ghadimi","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2025.103336_bib0017","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2025.103336_bib0018","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2025.103336_bib0019","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial","volume":"402","author":"Wainberg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2025.103336_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance Olaparib for Germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2025.103336_bib0021","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103336_bib0022","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002299","article-title":"Pancreatic cancer: failures and hopes-a review of new promising treatment approaches","volume":"6","author":"Cereda","year":"2025","journal-title":"Explor Target Antitumor Ther"},{"key":"10.1016\/j.arcmed.2025.103336_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2208470","article-title":"Sotorasib in KRAS p.G12C-mutated advanced pancreatic cancer","volume":"388","author":"Strickler","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2025.103336_bib0024","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRAS(G12D) inhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J Med Chem"},{"issue":"4_suppl","key":"10.1016\/j.arcmed.2025.103336_bib0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1200\/JCO.2025.43.4_suppl.722","article-title":"Safety, efficacy, and on-treatment circulating tumor DNA (ctDNA) changes from a phase 1 study of RMC-6236, a RAS(ON) multi-selective, tri-complex inhibitor, in patients with RAS mutant pancreatic ductal adenocarcinoma (PDAC)","volume":"43","author":"Garrido-Laguna","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/genes12010033","article-title":"Immune-based therapies and the role of microsatellite instability in pancreatic cancer","volume":"12","author":"Ghidini","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of Pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0028","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2025.103336_bib0029","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1200\/JCO.23.02585","article-title":"Dendritic cell-based immunotherapy in patients with resected pancreatic cancer","volume":"42","author":"van 't Land","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S2468-1253(18)30081-5","article-title":"Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2\u20133 trial","volume":"3","author":"Reni","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0031","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jjco\/hyy190","article-title":"Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP-05)","volume":"49","author":"Unno","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annonc.2022.09.161","article-title":"Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group","volume":"34","author":"Seufferlein","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0033","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","article-title":"Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial","volume":"8","author":"Ghaneh","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0034","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1245\/s10434-024-15011-7","article-title":"Adjuvant Gemcitabine versus Neoadjuvant\/Adjuvant FOLFIRINOX in resectable pancreatic cancer: the randomized multicenter Phase II NEPAFOX trial","volume":"31","author":"Goetze","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0035","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-24-01378","article-title":"Neoadjuvant FOLF(IRIN)OX chemotherapy for resectable pancreatic adenocarcinoma: A multicenter randomized noncomparative Phase II trial (PANACHE01 FRENCH08 PRODIGE48 study)","author":"Schwarz","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0036","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s11605-015-2890-4","article-title":"Neoadjuvant chemoradiotherapy and surgery versus surgery alone in resectable pancreatic cancer: A single-center prospective, randomized, controlled trial which failed to achieve accrual targets","volume":"19","author":"Casadei","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00066-014-0737-7","article-title":"Neoadjuvant chemoradiation therapy with gemcitabine\/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial","volume":"191","author":"Golcher","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0038","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/SLA.0000000000002705","article-title":"Oncological benefits of neoadjuvant chemoradiation with Gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: A prospective, randomized, open-label, Multicenter Phase 2\/3 trial","volume":"268","author":"Jang","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0039","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0040","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.20.00590","article-title":"Randomized phase III trial of pegvorhyaluronidase Alfa with Nab-Paclitaxel plus Gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma","volume":"38","author":"Van Cutsem","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0041","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.20.02232","article-title":"Randomized phase III study of FOLFOX alone or with Pegilodecakin as second-line therapy in patients with metastatic pancreatic cancer that progressed after Gemcitabine (SEQUOIA)","volume":"39","author":"Hecht","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0042","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of Gemcitabine with or without Erlotinib: the LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.arcmed.2025.103336_bib0043","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2017.72.6463","article-title":"CONKO-005: Adjuvant chemotherapy with Gemcitabine plus Erlotinib versus Gemcitabine alone in patients after R0 resection of pancreatic cancer: A multicenter randomized phase III trial","volume":"35","author":"Sinn","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0044","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.annonc.2021.01.070","article-title":"Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study","volume":"32","author":"Tempero","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0045","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1200\/JCO.23.02659","article-title":"Devimistat (CPI-613) with modified fluorouarcil, oxaliplatin, irinotecan, and leucovorin (FFX) versus FFX for patients with metastatic adenocarcinoma of the Pancreas: the Phase III AVENGER 500 study","volume":"42","author":"Philip","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0046","doi-asserted-by":"crossref","first-page":"eadh4567","DOI":"10.1126\/science.adh4567","article-title":"Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer","volume":"384","author":"Mahadevan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2025.103336_bib0047","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2025.103336_bib0048","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13045-019-0787-5","article-title":"Tumor neoantigens: from basic research to clinical applications","volume":"12","author":"Jiang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0049","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2025.103336_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejca.2022.03.015","article-title":"Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study","volume":"169","author":"Lau","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.arcmed.2025.103336_bib0051","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/carcin\/bgae065","article-title":"Exogenous or in situ vaccination to trigger clinical responses in pancreatic cancer","volume":"45","author":"Beatty","year":"2024","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.arcmed.2025.103336_bib0052","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2326-6066.CIR-14-0027","article-title":"Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation","volume":"2","author":"Lutz","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.arcmed.2025.103336_bib0053","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ccell.2022.10.001","article-title":"Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.arcmed.2025.103336_bib0054","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1038\/s41467-023-39196-9","article-title":"A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma","volume":"14","author":"Heumann","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.arcmed.2025.103336_bib0055","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2025.103336_bib0056","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13304-021-00996-7","article-title":"Pancreatoduodenectomy associated with colonic resections: indications, pitfalls, and outcomes","volume":"73","author":"Giuliani","year":"2021","journal-title":"Updates Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0057","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/SLA.0b013e3181ad657b","article-title":"Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome","volume":"250","author":"Hartwig","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0058","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jso.27160","article-title":"Short- and long-term surgical outcomes of pancreatic resection for retroperitoneal sarcoma: A long-term single-center experience of 90 cases","volume":"127","author":"Lv","year":"2023","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0059","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/jca.75456","article-title":"Short-term safety and long-term efficacy of multivisceral resection in pT4b gastric cancer patients without distant metastasis: a 20-year experience in China National Cancer Center","volume":"13","author":"Zhang","year":"2022","journal-title":"J Cancer"},{"key":"10.1016\/j.arcmed.2025.103336_bib0060","first-page":"372","article-title":"Treatment outcomes of multivisceral resection for locally advanced right colon cancer]","volume":"14","author":"Zhao","year":"2011","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"10.1016\/j.arcmed.2025.103336_bib0061","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/MPA.0b013e318220e3a4","article-title":"Robotic extended pancreatectomy with vascular resection for locally advanced pancreatic tumors","volume":"40","author":"Giulianotti","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.arcmed.2025.103336_bib0062","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.surg.2013.12.020","article-title":"Multivisceral and extended resections during pancreatoduodenectomy increase morbidity and mortality","volume":"155","author":"Bhayani","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.arcmed.2025.103336_bib0063","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hpb.2017.08.002","article-title":"Pancreatectomy combined with multivisceral resection for pancreatic malignancies: is it justified? Results of a systematic review","volume":"20","author":"Petrucciani","year":"2018","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0064","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11605-014-2725-8","article-title":"Perioperative and long-term outcome after standard pancreaticoduodenectomy, additional portal vein and multivisceral resection for pancreatic head cancer","volume":"19","author":"Kulemann","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0065","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s11605-008-0605-9","article-title":"Distal pancreatectomy is not associated with increased perioperative morbidity when performed as part of a multivisceral resection","volume":"12","author":"Irani","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0066","article-title":"Surgical treatment of locally advanced right colon cancer invading neighboring organs","volume":"9","author":"Ri","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0067","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1091-255X(01)00063-4","article-title":"En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?","volume":"6","author":"Sasson","year":"2002","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0068","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"Isaji","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.arcmed.2025.103336_bib0069","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41575-023-00856-2","article-title":"Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer","volume":"21","author":"Stoop","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/bjs.7270","article-title":"Arterial en bloc resection for pancreatic carcinoma","volume":"98","author":"Bockhorn","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0071","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00261-009-9539-2","article-title":"Surgical resectability of pancreatic adenocarcinoma: CTA","volume":"35","author":"Wong","year":"2010","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.arcmed.2025.103336_bib0072","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/bjs\/znab133","article-title":"Technical advances in surgery for pancreatic cancer","volume":"108","author":"Schneider","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0073","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000001850","article-title":"Locally advanced pancreatic cancer: neoadjuvant therapy with Folfirinox results in resectability in 60% of the patients","volume":"264","author":"Hackert","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0074","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/SLA.0000000000003301","article-title":"Surgery improves survival after neoadjuvant therapy for borderline and locally advanced pancreatic cancer: A single institution experience","volume":"273","author":"Rangelova","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/cancers11070893","article-title":"Nerves and pancreatic cancer: new insights into a dangerous relationship","volume":"11","author":"Gasparini","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0076","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.surg.2020.08.030","article-title":"Periarterial divestment in pancreatic cancer surgery","volume":"169","author":"Diener","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.arcmed.2025.103336_bib0077","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1245\/s10434-024-15303-y","article-title":"Periarterial and sub-adventitial divestment along with triangle operation and RAMPS for pancreatic body cancer","volume":"31","author":"Kumar","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0078","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/bjs.10603","article-title":"Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy","volume":"104","author":"Kleive","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0079","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s00268-012-1461-z","article-title":"Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis","volume":"36","author":"Zhou","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0080","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.pan.2022.05.001","article-title":"Venous resection for pancreatic cancer, a safe and feasible option? A systematic review and meta-analysis","volume":"22","author":"Zwart","year":"2022","journal-title":"Pancreatology"},{"key":"10.1016\/j.arcmed.2025.103336_bib0081","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1245\/s10434-018-07101-0","article-title":"Outcomes and risk score for distal pancreatectomy with celiac axis resection (DP-CAR): an international multicenter analysis","volume":"26","author":"Klompmaker","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0082","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1245\/s10434-018-6391-z","article-title":"Outcomes after distal pancreatectomy with celiac axis resection for pancreatic cancer: A Pan-European retrospective cohort study","volume":"25","author":"Klompmaker","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0083","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/SLA.0b013e31823ac299","article-title":"Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis","volume":"254","author":"Mollberg","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0084","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00423-020-01972-2","article-title":"Systematic review and meta-analysis of contemporary pancreas surgery with arterial resection","volume":"405","author":"Rebelo","year":"2020","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.hpb.2018.07.017","article-title":"Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer","volume":"21","author":"Del Chiaro","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0086","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/hpb.12205","article-title":"Anticoagulation policy after venous resection with a pancreatectomy: a systematic review","volume":"16","author":"Chandrasegaram","year":"2014","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0087","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archsurg.138.7.777","article-title":"Robotics in general surgery: personal experience in a large community hospital","volume":"138","author":"Giulianotti","year":"2003","journal-title":"Arch Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0088","doi-asserted-by":"crossref","first-page":"106","DOI":"10.21037\/jovs.2017.07.02","article-title":"Developing a robotic pancreas program: the Dutch experience","volume":"3","author":"Nota","year":"2017","journal-title":"J Vis Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0089","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/SLA.0b013e3182a4e87c","article-title":"250 robotic pancreatic resections: safety and feasibility","volume":"258","author":"Zureikat","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/109264203321235449","article-title":"Robotic resection of pancreatic neuroendocrine tumor","volume":"13","author":"Melvin","year":"2003","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"10.1016\/j.arcmed.2025.103336_bib0091","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1007\/s00464-023-09894-y","article-title":"Robot-assisted versus laparoscopic distal pancreatectomy: a systematic review and meta-analysis including patient subgroups","volume":"37","author":"van Ramshorst","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.arcmed.2025.103336_bib0092","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.asjsur.2018.08.011","article-title":"Comparison of surgical outcomes of robot-assisted laparoscopic distal pancreatectomy versus laparoscopic and open resections: A systematic review and meta-analysis","volume":"42","author":"Niu","year":"2019","journal-title":"Asian J Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0093","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13304-022-01413-3","article-title":"Robotic versus laparoscopic distal pancreatectomy on perioperative outcomes: a systematic review and meta-analysis","volume":"75","author":"Li","year":"2023","journal-title":"Updates Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0094","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jso.25958","article-title":"Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma","volume":"122","author":"Nassour","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.hpb.2016.04.008","article-title":"Robotic versus laparoscopic distal pancreatectomy - the first meta-analysis","volume":"18","author":"Gavriilidis","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0096","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejso.2018.12.003","article-title":"Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: A systematic review and meta-analysis","volume":"45","author":"van Hilst","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0097","article-title":"Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial","volume":"31","author":"Korrel","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.arcmed.2025.103336_bib0098","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11701-021-01289-2","article-title":"Robotic pancreas surgery: an overview of history and update on technique, outcomes, and financials","volume":"16","author":"Khachfe","year":"2022","journal-title":"J Robot Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0099","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2468-1253(19)30004-4","article-title":"Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2\/3 trial","volume":"4","author":"van Hilst","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0100","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/jamasurg.2015.17","article-title":"Assessment of quality outcomes for robotic pancreaticoduodenectomy: identification of the learning curve","volume":"150","author":"Boone","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0101","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/SLA.0000000000001869","article-title":"A multi-institutional comparison of perioperative outcomes of robotic and open pancreaticoduodenectomy","volume":"264","author":"Zureikat","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0102","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae043","article-title":"Early experience with robotic pancreatoduodenectomy versus open pancreatoduodenectomy: nationwide propensity-score-matched analysis","volume":"111","author":"de Graaf","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0103","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1097\/SLA.0000000000005160","article-title":"Perioperative and oncological outcomes of robotic versus open pancreaticoduodenectomy in low-risk surgical candidates: A multicenter propensity score-matched study","volume":"277","author":"Liu","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0104","article-title":"Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial","volume":"39","author":"Klotz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.arcmed.2025.103336_bib0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(24)00005-0","article-title":"Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open-label randomised controlled trial","volume":"9","author":"Liu","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0106","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00464-021-08439-5","article-title":"Learning curve of three European centers in laparoscopic, hybrid laparoscopic, and robotic pancreatoduodenectomy","volume":"36","author":"Tyutyunnik","year":"2022","journal-title":"Surg Endosc"},{"key":"10.1016\/j.arcmed.2025.103336_bib0107","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/AS9.0000000000000111","article-title":"Learning curves in open, laparoscopic, and robotic pancreatic surgery: A systematic review and proposal of a standardization","volume":"3","author":"M\u00fcller","year":"2022","journal-title":"Ann Surg Open"},{"key":"10.1016\/j.arcmed.2025.103336_bib0108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1457496920911815","article-title":"Robotic pancreatoduodenectomy: patient selection, volume criteria, and training programs","volume":"109","author":"Jones","year":"2020","journal-title":"Scand J Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0109","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1007\/s00464-023-09941-8","article-title":"The influence of procedural volume on short-term outcomes for robotic pancreatoduodenectomy-a cohort study and a learning curve analysis","volume":"37","author":"Kawka","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.arcmed.2025.103336_bib0110","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/rcs.1688","article-title":"Robotic pancreaticoduodenectomy: comparison of complications and cost to the open approach","volume":"12","author":"Baker","year":"2016","journal-title":"Int J Med Robot"},{"key":"10.1016\/j.arcmed.2025.103336_bib0111","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000006665","article-title":"Cost-analysis of implementing robot-assisted versus open pancreatoduodenectomy","author":"Menso","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0112","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.hpb.2020.10.001","article-title":"Enucleation for benign or borderline tumors of the pancreas: comparing open and minimally invasive surgery","volume":"23","author":"Ei","year":"2021","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0113","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.hpb.2023.02.014","article-title":"Minimally-invasive versus open pancreatic enucleation: systematic review and metanalysis of short-term outcomes","volume":"25","author":"Roesel","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.arcmed.2025.103336_bib0114","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00464-016-5046-z","article-title":"Robot-assisted laparoscopic versus open middle pancreatectomy: short-term results of a randomized controlled trial","volume":"31","author":"Chen","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1016\/j.arcmed.2025.103336_bib0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.21037\/hbsn.2020.03.19","article-title":"Robotic-assisted versus open total pancreatectomy: a propensity score-matched study","volume":"9","author":"Weng","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.arcmed.2025.103336_bib0116","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00464-014-3656-x","article-title":"Robotic total pancreatectomy with or without autologous islet cell transplantation: replication of an open technique through a minimal access approach","volume":"29","author":"Zureikat","year":"2015","journal-title":"Surg Endosc"},{"key":"10.1016\/j.arcmed.2025.103336_bib0117","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13304-022-01255-z","article-title":"The role of artificial intelligence in pancreatic surgery: a systematic review","volume":"74","author":"Schlanger","year":"2022","journal-title":"Updates Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0118","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.3748\/wjg.v26.i30.4453","article-title":"Risk prediction platform for pancreatic fistula after pancreatoduodenectomy using artificial intelligence","volume":"26","author":"Han","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0119","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.surg.2019.09.019","article-title":"The potential of machine learning to predict postoperative pancreatic fistula based on preoperative, non-contrast-enhanced CT: A proof-of-principle study","volume":"167","author":"Kambakamba","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.arcmed.2025.103336_bib0120","article-title":"Predicting metastasis risk in pancreatic neuroendocrine tumors using deep learning image analysis","volume":"10","author":"Klimov","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2025.103336_bib0121","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4174\/astr.2022.102.3.147","article-title":"External validation of risk prediction platforms for pancreatic fistula after pancreatoduodenectomy using nomograms and artificial intelligence","volume":"102","author":"Yoon","year":"2022","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.arcmed.2025.103336_bib0122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259682","article-title":"Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree","volume":"16","author":"Wakiya","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2025.103336_bib0123","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1097\/AS9.0000000000000516","article-title":"Enhancing perioperative outcomes of pancreatic surgery with wearable augmented reality assistance system: A matched-pair analysis","volume":"5","author":"Javaheri","year":"2024","journal-title":"Ann Surg Open"},{"key":"10.1016\/j.arcmed.2025.103336_bib0124","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1007\/s00464-022-09195-w","article-title":"Augmented reality navigation facilitates laparoscopic removal of foreign body in the pancreas that cause chronic complications","volume":"36","author":"Lin","year":"2022","journal-title":"Surg Endosc"},{"key":"10.1016\/j.arcmed.2025.103336_bib0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fsurg.2020.00038","article-title":"Case report: virtual and interactive 3D vascular reconstruction before planned pancreatic head resection and complex vascular anatomy: A bench-to-bedside transfer of new visualization techniques in pancreatic surgery","volume":"7","author":"Templin","year":"2020","journal-title":"Front Surg"},{"key":"10.1016\/j.arcmed.2025.103336_bib0126","doi-asserted-by":"crossref","first-page":"e2623","DOI":"10.1002\/rcs.2623","article-title":"An analysis of virtual reality in abdominal surgery-A scoping review","volume":"20","author":"Ochs","year":"2024","journal-title":"Int J Med Robot"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:22:14Z","timestamp":1765617734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440925001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":126,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0188440925001560"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103336","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future of Pancreatic Cancer Therapy: Getting Better, But not Good Enough Ye","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Instituto Mexicano del Seguro Social (IMSS).","name":"copyright","label":"Copyright"}],"article-number":"103336"}}